From Rick Laferriere Utah drug research company, Curza, takes aim at Lyme disease By Chris Miller, KUTV-TV, Salt Lake City, Utah August 25, 2015 http://kutv.com/news/local/utah-drug-research-company-curza-takes-aim-at-lyme-disease or http://tinyurl.com/pdpatqh Curza, a Provo-based pharmaceutical research company, is on the cusp of a medical breakthrough that could treat victims of chronic Lyme disease. The company is entering phase two of clinical research on their newly designed antibiotic called CZ-99. They'll soon be testing the drug on infected mice at the University of California, Davis. An initial clinical trial at the University of New Haven in Connecticut, found CZ-99 to be 60 percent more effective in treating Lyme disease than the traditional antibiotics used to treat the illness. Curza CEO Ryan Davies says they have a patent on a technology used to penetrate bacteria's protective outer layer, or biofilm, making its new antibiotic more effective than outdated medications.